Arthroplasty

Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

Retrieved on: 
Monday, April 8, 2024
Failure, De novo, Health, Prevalence, Infection, Arthroplasty, Patient, Trauma, Mortality, Bacteria, Osteoporosis, Food and Drug Administration, Neoplasm, Amputation, FDA, Onko, Pharmaceutical industry

PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ -- Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants. Bacterial contamination of a permanent implant may have devastating effects, particularly in orthopedic oncology and revision arthroplasty applications where the patient population is highly vulnerable.

Key Points: 
  • PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ -- Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.
  • Bacterial contamination of a permanent implant may have devastating effects, particularly in orthopedic oncology and revision arthroplasty applications where the patient population is highly vulnerable.
  • "Implant contamination is a growing concern to the orthopaedic surgical community," said Steven Gitelis, MD, Onkos Surgical Chief Medical Officer, Rush Medical College, Endowed Professor of Orthopaedic Oncology and Director, Musculoskeletal Oncology at Rush Cancer Center.
  • The Onkos technology is a significant innovation and another option to help reduce local bacterial load on the implant."

Centinel Spine® to Sponsor Major Worldwide Live Webinar Symposium on Cervical Disc Arthroplasty

Retrieved on: 
Thursday, March 21, 2024
Arthroplasty, PD, Patient, The Company, Doctor of Philosophy, MD, Samuel Bryan, Surgeon, TDR, Spine

This live webinar symposium is open to all spine surgeons worldwide and led by an internationally esteemed group of total disc replacement (TDR) experts.

Key Points: 
  • This live webinar symposium is open to all spine surgeons worldwide and led by an internationally esteemed group of total disc replacement (TDR) experts.
  • A webinar link will allow surgeons worldwide to join for the live presentations, beginning on April 3, 2024 at 8:00am AEDT (April 2, 2024 at 5:00pm EDT U.S.).
  • This symposium is supported by Centinel Spine's global medical education program and is focused on the current state of TDR options for patients with chronic cervical disc disease.
  • Summing up, course co-director Dr. Scott Blumenthal notes, "I strongly encourage any surgeon interested in cervical total disc arthroplasty to attend this symposium.

Studies Show AI Chatbots Provide Inconsistent Accuracy for Musculoskeletal Health Information

Retrieved on: 
Monday, February 12, 2024
Bias, SAN, Outline, Artificial intelligence, MD, Physician, Hospital, Surgeon, FAQ, Weill Cornell Medicine, Bing'ai, LLM, Arthroplasty, Patient, Knee, AAOS, OpenAI, Research, American Academy, Medical device

Three new studies presented at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) analyzed the validity of the information chatbots gave to patients for certain orthopaedic procedures, assessing the accuracy of how chatbots present research advancements and clinical decision making.

Key Points: 
  • Three new studies presented at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) analyzed the validity of the information chatbots gave to patients for certain orthopaedic procedures, assessing the accuracy of how chatbots present research advancements and clinical decision making.
  • While the studies found that certain chatbots provide concise summaries across a wide spectrum of orthopaedic conditions, each demonstrated limited accuracy depending on the category.
  • This study, led by Branden Sosa, a fourth-year medical student at Weill Cornell Medicine, assessed the accuracy of Open AI ChatGPT 4.0, Google Bard and BingAI chatbots to explain basic orthopaedic concepts, integrate clinical information and address patient queries.
  • Each chatbot was prompted to answer 45 orthopaedic-related questions spanning categories of "Bone Physiology," "Referring Physician," and "Patient Query" and then assessed for accuracy.

Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle

Retrieved on: 
Wednesday, January 31, 2024
Health, Medical Devices, Surgery, Other Health, General Health, Pharmaceutical, Biotechnology, Surgeon, American College, DPM, Infinity, Patient, Arthroplasty, Footprint, Pathology, Estate (law), SYK, Ankle, ACFAS, Annual general meeting, Pharmaceutical industry

Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot.

Key Points: 
  • Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot.
  • The system will be demonstrated at the American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting , Tampa Bay, Fla., Feb. 1-4 (booth #919).
  • The launch of Prophecy Footprint also coincides with the tenth anniversary of Stryker’s Infinity Total Ankle System, a low-profile implant indicated for total ankle replacement in patients with end-stage ankle arthritis.
  • Prophecy Footprint elevates surgical planning by providing comprehensive procedural considerations that address concomitant pathology at the time of total ankle arthroplasty.

Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting

Retrieved on: 
Monday, October 30, 2023
NYSE, ENOV, Rotation, Journal, Hip, Surgeon, Knee, 3D printing, Arthroplasty

“Enovis is dedicated to surgeon-centric innovation that creates value for all stakeholders and ultimately improves patient outcomes,” stated Louie Vogt, President and General Manager of Enovis™ Surgical.

Key Points: 
  • “Enovis is dedicated to surgeon-centric innovation that creates value for all stakeholders and ultimately improves patient outcomes,” stated Louie Vogt, President and General Manager of Enovis™ Surgical.
  • AAHKS attendees can experience these products firsthand at booth #501.
  • A dual-pivot pattern simulating native knee kinematics optimizes functional outcomes after total knee arthroplasty.
  • "Dual-pivot bearings improve ambulation and promote increased activity levels in Total knee arthroplasty: A match-controlled retrospective study."

Newton Surgeon Using Groundbreaking Technology for Guided Personalized Shoulder Replacement Surgeries

Retrieved on: 
Wednesday, November 1, 2023
Technology, Surgery, Medical Devices, Hospitals, Health Technology, Practice Management, Biotechnology, Hardware, Health, Anatomy, GPS, Surgeon, Shoulder, Scientific Reports, Glenoid fossa, CT, Patient, Dentistry, Satellite navigation device, Medical device, Arthroplasty

Orthopaedic surgeon Dr. Daniel Quinn is now using computer-assisted technology to offer guided personalized surgery for shoulder replacements in the area.

Key Points: 
  • Orthopaedic surgeon Dr. Daniel Quinn is now using computer-assisted technology to offer guided personalized surgery for shoulder replacements in the area.
  • ExactechGPS® Guided Personalized Surgery is the latest advancement in technology that provides surgeons with real-time visual guidance and alignment data in total shoulder surgery.
  • “With GPS, I have complete control over my patients’ shoulder replacement surgery,” said Dr. Quinn.
  • “This technology gives me the ability to pair each patient’s personalized plan prior to surgery with real-time intraoperative guidance to ensure proper implant placement.

L2P Research Labs Awarded NIH SBIR Grant for Arthritis, Musculoskeletal and Skin Diseases Research

Retrieved on: 
Friday, October 27, 2023
Pharmaceutical, Science, Health, Research, Stem cell, Labs, MSC, Pain management, Pain, ASC, Motion, Hydrogel, Arthroplasty, B cell, Medical imaging, Osteoarthritis

No treatments other than arthroplasty have been developed to stop its progression, reduce pain, and increase range of motion.

Key Points: 
  • No treatments other than arthroplasty have been developed to stop its progression, reduce pain, and increase range of motion.
  • L2P Labs will aim to combine the use of hydrogel, stem cells, and ultrasound therapy to develop a new treatment for osteoarthritis.
  • Dr. Suresh Anaganti, Chief Executive Officer of L2P Research, added “This research will address a huge unmet need for disease modification (compared to mere pain management) in the osteoarthritis field.
  • Importantly, these experiments have been designed to facilitate a rapid proof-of-concept to pave the way for future clinical studies.”

88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions

Retrieved on: 
Sunday, October 29, 2023
Biomedical engineering, 3D, Child, Exhibition, Electronics, MRI, Genetic testing, Endoscopy, Convention center, Mobile robot, IVD, Arthroplasty, Mako, Robotics, Medicine, Medical imaging, Hong Kong International Medical Devices and Supplies Fair, POCT, OR, Growth, Life expectancy, Hip, World Bank, Knee, Instrument, Nursing care plan, Medical optical imaging

The CMEF has always been a key international platform for global medical equipment enterprises to showcase their innovative strength.

Key Points: 
  • The CMEF has always been a key international platform for global medical equipment enterprises to showcase their innovative strength.
  • Medical Optics: focused on presenting total solutions for OR endoscopy, digestive endoscopy systems for early cancer screening, and full HD electronic endoscopy systems.
  • Operating Room: presenting the new solutions of integrated operating room, digital composite operating room, OR/ICU equipment integration solutions.
  • CMEF will remain dedicated to the medical equipment industry, keeping abreast of the latest technology, product development, and market trends.

88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions

Retrieved on: 
Sunday, October 29, 2023
Biomedical engineering, 3D, Child, Exhibition, Electronics, MRI, Genetic testing, Endoscopy, Convention center, Mobile robot, IVD, Arthroplasty, Mako, Robotics, Medicine, Medical imaging, Hong Kong International Medical Devices and Supplies Fair, POCT, Multimedia, OR, Growth, Life expectancy, Hip, World Bank, Knee, Instrument, Nursing care plan, Medical optical imaging

The CMEF has always been a key international platform for global medical equipment enterprises to showcase their innovative strength.

Key Points: 
  • The CMEF has always been a key international platform for global medical equipment enterprises to showcase their innovative strength.
  • Medical Optics: focused on presenting total solutions for OR endoscopy, digestive endoscopy systems for early cancer screening, and full HD electronic endoscopy systems.
  • Operating Room: presenting the new solutions of integrated operating room, digital composite operating room, OR/ICU equipment integration solutions.
  • CMEF will remain dedicated to the medical equipment industry, keeping abreast of the latest technology, product development, and market trends.

Centinel Spine® PMA Application for First-of-its-Kind 2-Level prodisc® C Vivo and prodisc C SK Match-the-Disc™ Cervical Total Disc Replacement System Filed and Proceeding with Substantive Review

Retrieved on: 
Thursday, October 26, 2023
Anatomy, FDA, Arthroplasty, Investigational device exemption, Food, TDR, Health, PMA, WEST, IDE, Clinical trial, Surgeon, Samuel Bryan, Safety, SK, Food and Drug Administration Amendments Act of 2007, Pharmaceutical industry, Medical device

The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as a control for 2-level indications.

Key Points: 
  • The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as a control for 2-level indications.
  • The filing date for the Company's PMA application was September 27, 2023 and the submission is now under substantive review by the FDA.
  • "The prodisc C Vivo and prodisc C SK 2-level cervical disc clinical trial was unique in two ways," said Centinel Spine CEO Steve Murray.
  • The prodisc C Vivo system has been in clinical use internationally since 2009 and is currently one of the most frequently implanted TDR devices in the world.